Prescription Orthopedic Drugs Market Size Forecasted To Achieve 65.31 Billion By 2029 With Steady Growth

"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Prescription Orthopedic Drugs Market Size and Projected Growth Rate?
The market for prescription orthopedic drugs has seen robust growth in recent years, expanding from a size of $48.41 billion in 2024 to an estimated $51.55 billion in 2025. This represents a compound annual growth rate (CAGR) of 6.5%. The surge during this historic period is tied to several factors - more widespread cases of musculoskeletal disorders, a growing demographic of elderly people, heightened knowledge about treatments for osteoporosis, broader healthcare access in emerging regions, and a rise in global sports-related injuries.

The market for prescription orthopedic drugs is forecasted to witness robust growth in the near future, increasing to a value of $65.32 billion by 2029, at a compound annual growth rate (CAGR) of 6.1%. Elements contributing towards this surge during the predicted timeline include a mounting need for biologics, a rising senior population, a progressive expansion of healthcare accessibility in emerging markets, a growing prevalence of long-lasting musculoskeletal disorder, and heightened funding towards research and development in the orthopedic drug industry. Notable trends for this upcoming period encompass developments in targeted biologics, the embracing of regenerative medicine treatments, customized drug combinations, progress in minimally invasive delivery mechanisms, improved drug effectiveness owing to gene therapy, groundbreaking developments in injectable formulations, and evolution in artificial intelligence utilized for drug creation and clinical decision making.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21263

What Are the Major Segments in the Prescription Orthopedic Drugs Market?
The prescription orthopedic drugs market covered in this report is segmented -

1) By Drug Type: Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Other Drug Types
2) By Application: Osteoarthritis, Rheumatoid Arthritis, Osteoporosis, Other Applications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:
1) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Ibuprofen, Naproxen, Diclofenac, Celecoxib, Indomethacin
2) By Opioids: Morphine, Oxycodone, Hydrocodone, Fentanyl, Tram*adol
3) By Corticosteroids: Prednisone, Methylprednisolone, Dexamethasone, Hydrocortisone, Betamethasone
4) By Disease-Modifying Antirheumatic Drugs (DMARDs): Methotrexate, Hydroxychloroquine, Leflunomide, Sulfasalazine, Azathioprine
5) By Other Drug Types: Bisphosphonates, Calcitonin, Monoclonal Antibodies, Muscle Relaxants, Hyaluronic Acid Injections

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21263&type=smp

What Are The Driving Prescription Orthopedic Drugs Market Evolution?
Growth in the prescription orthopedic drugs market is anticipated to be fueled by the escalating prevalence of musculoskeletal disorders. Such disorders refer to conditions and injuries that impair the function and mobility of the human body's musculoskeletal system, encompassing muscles, tendons, ligaments, nerves, and joints, and often result in pain and hindered mobility. The primary reasons behind this growing prevalence are factors such as aging, repetitive movements and awkward positions in work-related activities, poor nutrition and lack of physical activity in lifestyle choices, and inherent genetic factors. Prescription orthopedic medicines are crucial in handling these disorders by alleviating pain, curbing inflammation, and facilitating the healing process, consequently enhancing mobility and the overall quality of life. For example, the Office for Health Improvement and Disparities, a UK-based public health government department, reported in March 2023, that the percentage of individuals aged 16 and above suffering from a long-term musculoskeletal condition, like arthritis or persistent joint or back issues, had increased to 17.6% in 2022, up from 17.0% in 2021. Furthermore, the World Health Organization, an intergovernmental organization based in Switzerland, reported in July 2022 that approximately 1.71 billion individuals globally were affected by musculoskeletal disorders. Hence, this growing prevalence is fueling the expansion of the prescription orthopedic drugs market.

Which Firms Dominate The Prescription Orthopedic Drugs Market Segments?
Major companies operating in the prescription orthopedic drugs market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck KGaA, AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, GSK Plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Biogen Inc., UCB S.A., Allergan plc, Penardo Biotech Pvt. Ltd., Horizon Therapeutics plc

What Prescription Orthopedic Drugs Market Trends Are Gaining Traction Across Different Segments?
Big players in the prescription orthopedic drugs market are adopting strategies to broaden indications for their drugs, with the aim to extend their market presence, augment patient results, and cater to unmet medical necessities linked to various orthopedic conditions. For example, in January 2023, Heron Therapeutics Inc., a biotechnology firm based in the US, obtained FDA approval for the expanded use of ZYNRELEF (bupivacaine and meloxicam) for soft tissue and orthopedic procedures, incorporating foot and ankle surgeries. This advanced release solution is distinctively designed to offer extended pain relief up to 72 hours, thus reducing or entirely eliminating the requirement for opioids after surgery. The broadened connotation now includes additional orthopedic and soft tissue processes, comprising foot and ankle surgeries, expanding its usage in clinical environments. With its unique dual-drug combination, it yields both local anesthetic and anti-inflammatory benefits, making it a comprehensive choice for managing post-surgery pain with improved patient outcomes.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/prescription-orthopedic-drugs-global-market-report

Which Is The Largest Region In The Prescription Orthopedic Drugs Market?
North America was the largest region in the prescription orthopedic drugs market in 2024. The regions covered in the prescription orthopedic drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Prescription Orthopedic Drugs Market?
2. What is the CAGR expected in the Prescription Orthopedic Drugs Market?
3. What Are the Key Innovations Transforming the Prescription Orthopedic Drugs Industry?
4. Which Region Is Leading the Prescription Orthopedic Drugs Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments."

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.